168 results on '"Vincent, Sandra"'
Search Results
2. Sex- and age-adjusted reference values for dynamic inspiratory constraints during incremental cycle ergometry
3. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
4. Neurophysiological Mechanisms of Exertional Dyspnea in Patient’s Post-Pulmonary Embolism: The Effect of Inhaled Nitric Oxide
5. Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
6. Compensatory responses to increased mechanical abnormalities in COPD during sleep
7. In vivo cardiopulmonary impact of skeletal M3Dq DREADD expression: a pilot study
8. Reference values for leg effort during incremental cycle ergometry in non‐trained healthy men and women, aged 19–85
9. Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD
10. Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity
11. Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance.
12. Late Breaking Abstract - Systemic Determinants of Exercise Intolerance in Patients with Fibrosing Interstitial Lung Disease and a Severely Impaired DLCO
13. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO
14. A country-wide survey of Varroa destructor , an ectoparasitic mite of honey bees, in Nigeria: determination of mitochondrial haplotype
15. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO.
16. A country-wide survey of Varroa destructor, an ectoparasitic mite of honey bees, in Nigeria: determination of mitochondrial haplotype.
17. Online Data Supplement: Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
18. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
19. Neurophysiological Mechanisms of Exertional Dyspnea in Post-Pulmonary Embolism Syndrome
20. Interaction of Hypoxia and Core Temperature: Potential Role of TRPV1
21. Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
22. Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study
23. Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema.
24. Mechanosensitivity of Murine Lung Slowly Adapting Receptors: Minimal Impact of Chemosensory, Serotonergic, and Purinergic Signaling
25. Severe exertional dyspnoea in COPD: Implications for exercise tolerance and survival
26. Components of dyspnoea during incremental exercise across the COPD continuum
27. Low DLCO, reduced pulmonary blood volume and ventilatory inefficiency in smokers with mild emphysema
28. Mechanisms of Exertional Dyspnea in Patients with Mild COPD and a Low Resting DLCO
29. Exertional dyspnoea in patients with mild‐to‐severe chronic obstructive pulmonary disease: neuromechanical mechanisms.
30. Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength.
31. Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum
32. Supplementary_Data - The safety evaluation of phycocyanin-enriched Galdieria sulphuraria extract using 90-day toxicity study in rats and in vitro genotoxicity studies
33. Reviewer_1_v.1 – Supplemental material for Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
34. Deterioration of Nighttime Respiratory Mechanics in COPD
35. Evaluation of Dynamic Respiratory Mechanical Abnormalities During Conventional CPET
36. The safety evaluation of phycocyanin-enrichedGaldieria sulphurariaextract using 90-day toxicity study in rats and in vitro genotoxicity studies
37. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
38. Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum.
39. In vivo cardiopulmonary impact of skeletal M3Dq DREADD expression: a pilot study.
40. DLCO and exercise intolerance_Online supplement_JAP_July 16 2019.docx
41. Low Resting Diffusion Capacity, Dyspnea and Exercise Intolerance in COPD_Online supplement_July 16 2019.docx
42. Mechanisms of Exertional Dyspnea in Patients with Mild COPD and a Low Resting DLCO.
43. Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency.
44. The link between low resting diffusion capacity and exercise intolerance in COPD
45. Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences
46. A country-wide survey ofVarroa destructor, an ectoparasitic mite of honey bees, in Nigeria: a preliminary report
47. Unraveling the Causes of Unexplained Dyspnea
48. A country-wide survey of Varroa destructor, an ectoparasitic mite of honey bees, in Nigeria: a preliminary report.
49. Severe Exertional Dyspnea in an Ex-Smoker with a Large Apical Bulla
50. A new report of Varroa destructor, an ectoparasitic mite of honey bees, from Bauchi State, Nigeria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.